Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers

Eur J Dermatol. 2011 Mar-Apr;21(2):263-4. doi: 10.1684/ejd.2010.1235.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects
  • Crohn Disease / chemically induced
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects
  • Psoriasis / chemically induced
  • Receptors, Tumor Necrosis Factor
  • Spondylitis, Ankylosing / complications*
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Adalimumab
  • Etanercept